Your browser doesn't support javascript.
loading
Biosimilar Rituximab (Redditux) Added to CHOP Chemotherapy for De Novo Diffuse Large B-Cell Lymphoma Patients: Real-Life Single-Center Experience
Özbalak, Murat; Güzel Mastanzade, Metban; Özlük, Özden; Tiryaki, Tarik Onur; Erdem, Simge; Özbalak, Ezgi Pinar; Elverdi, Tugrul; Yönal Hindilerden, Ipek; Altay, Ali Yilmaz; Yegen, Gülçin; Eskazan, Ahmet Emre; Ar, Muhlis Cem; Yenerel, Mustafa Nuri; Soysal, Teoman; Nalçaci, Meliha; Ferhanoglu, Burhan; Kalayoglu Besisik, Sevgi.
Afiliación
  • Özbalak M; Istanbul University, Istanbul Medical Faculty, Department of Internal Medicine, Division of Hematology, Istanbul, Turkey
  • Güzel Mastanzade M; Istanbul University, Istanbul Medical Faculty, Department of Internal Medicine, Division of Hematology, Istanbul, Turkey
  • Özlük Ö; Istanbul University, Istanbul Medical Faculty, Department of Internal Medicine, Division of Hematology, Istanbul, Turkey
  • Tiryaki TO; Istanbul University, Istanbul Medical Faculty, Department of Internal Medicine, Division of Hematology, Istanbul, Turkey
  • Erdem S; Istanbul University, Istanbul Medical Faculty, Department of Internal Medicine, Division of Hematology, Istanbul, Turkey
  • Özbalak EP; Istanbul University, Istanbul Medical Faculty, Department of Internal Medicine, Division of Hematology, Istanbul, Turkey
  • Elverdi T; Istanbul University-Cerrahpasa, Cerrahpasa Medical Faculty, Department of Internal Medicine, Division of Hematology, Istanbul, Turkey
  • Yönal Hindilerden I; Istanbul University, Istanbul Medical Faculty, Department of Internal Medicine, Division of Hematology, Istanbul, Turkey
  • Altay AY; Istanbul University, Istanbul Medical Faculty, Department of Pathology, Division of Hematopathology, Istanbul, Turkey
  • Yegen G; Istanbul University, Istanbul Medical Faculty, Department of Pathology, Division of Hematopathology, Istanbul, Turkey
  • Eskazan AE; Istanbul University-Cerrahpasa, Cerrahpasa Medical Faculty, Department of Internal Medicine, Division of Hematology, Istanbul, Turkey
  • Ar MC; Istanbul University-Cerrahpasa, Cerrahpasa Medical Faculty, Department of Internal Medicine, Division of Hematology, Istanbul, Turkey
  • Yenerel MN; Istanbul University, Istanbul Medical Faculty, Department of Internal Medicine, Division of Hematology, Istanbul, Turkey
  • Soysal T; Istanbul University-Cerrahpasa, Cerrahpasa Medical Faculty, Department of Internal Medicine, Division of Hematology, Istanbul, Turkey
  • Nalçaci M; Istanbul University, Istanbul Medical Faculty, Department of Internal Medicine, Division of Hematology, Istanbul, Turkey
  • Ferhanoglu B; V.K.V. American Hospital, Department of Internal Medicine, Division of Hematology, Istanbul, Turkey
  • Kalayoglu Besisik S; Istanbul University, Istanbul Medical Faculty, Department of Internal Medicine, Division of Hematology, Istanbul, Turkey
Turk J Haematol ; 39(4): 254-261, 2022 12 01.
Article en En | MEDLINE | ID: mdl-35657203
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Linfoma de Células B Grandes Difuso / Biosimilares Farmacéuticos Tipo de estudio: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Turk J Haematol Año: 2022 Tipo del documento: Article País de afiliación: Turquía Pais de publicación: Turquía
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Linfoma de Células B Grandes Difuso / Biosimilares Farmacéuticos Tipo de estudio: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Turk J Haematol Año: 2022 Tipo del documento: Article País de afiliación: Turquía Pais de publicación: Turquía